GARLAND E. BURRELL, Jr., Senior District Judge.
Plaintiff Cesca Therapeutics Inc. ("Cesca") and Defendants SynGen Inc., PHC Medical, Inc., Philip Coelho, Terrence Wolf, and Prince Emmanuel (collectively "Defendants"), by and through their respective counsel, hereby stipulate as follows:
WHEREAS, on September 9, 2014, Cesca filed its Complaint in the above-captioned matter;
WHEREAS, on September 23, 2014, the parties filed a joint stipulation extending Defendants' time to answer or otherwise respond to Cesca's Complaint by 28 days, pursuant to Local Rule 144(a);
WHEREAS, on October 21, 2014, the parties filed a second joint stipulation extending Defendants' time to answer or otherwise respond to Cesca's Complaint by another 21 days, pursuant to Local Rule 144(a);
WHEREAS, on November 13, 2014, the parties filed a third joint stipulation extending Defendants' time to answer or otherwise respond to Cesca's Complaint by another 21 days, pursuant to Local Rule 144(a);
WHEREAS, Weintraub Tobin Chediak Coleman Grodin and Paul Hastings LLP, counsel for Cesca, will be withdrawing from this case, and
WHEREAS, in light of this withdrawal and because new counsel for Cesca has not yet appeared, the parties have agreed to extend Defendants' time to answer or otherwise respond to Cesca's Complaint by another 21 days.
NOW, THEREFORE, it is hereby stipulated and agreed that:
With permission of the Court, Defendants shall have until and including December 31, 2014 to answer or otherwise respond to Cesca's Complaint.